Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate model.
Koichi AzumaHuihui XiangTomoyuki TagamiRika KasajimaYumiko KatoSachise KarakawaShinya KikuchiAkira ImaizumiNorikazu MatsuoHidenobu IshiiTakaaki TokitoAkihiko KawaharaKenta MurotaniTetsuro SasadaYohei MiyagiTomoaki HoshinoPublished in: Journal for immunotherapy of cancer (2022)
The multivariate model with PFAAs and metabolites in plasma might be useful for stratifying patients who will benefit from PD-1 inhibitors.